Canopy Growth Corp
CGC · Nasdaq · SIC 2833: Medicinal Chemicals & Botanical Products
Business Summary
6 Item 1A. Risk Factors 26 Item 1B. Unresolved Staff Comments 58 Item 1C. Cybersecurity 58 Item 2. Properties 59 Item 3. Legal Proceedings 60 Item 4. Mine Safety Disclosures 61 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 62 Item 6. Reserved 62 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 63 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 95 Item 8. F...
Next Earnings
Q2 FY2026 — expected 2026-09-17
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | CGC | discussed_in_filing Cybersecurity | |
| topic_mention | CGC | discussed_in_filing Cybersecurity | |
| topic_mention | CGC | discussed_in_filing Cybersecurity | |
| topic_mention | CGC | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-05-30 | 2025-03-31 | 0000950170-25-079317 | EDGAR | 164K words |
| 2024-05-30 | 2024-03-31 | 0000950170-24-066240 | EDGAR | — |
| 2023-06-22 | 2023-03-31 | 0000950170-23-029420 | EDGAR | — |
| 2022-05-31 | 2022-03-31 | 0001564590-22-021923 | EDGAR | — |
| 2021-06-01 | 2021-03-31 | 0001564590-21-031214 | EDGAR | — |
| 2020-06-01 | 2020-03-31 | 0001564590-20-027897 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-02-06 | 2025-12-31 | 0001193125-26-040275 | EDGAR | 50K words |
| 2025-11-07 | 2025-09-30 | 0001193125-25-270960 | EDGAR | — |
| 2025-08-08 | 2025-06-30 | 0001193125-25-175982 | EDGAR | — |
| 2025-02-07 | 2024-12-31 | 0000950170-25-015839 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0000950170-24-123672 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0000950170-24-094330 | EDGAR | — |
| 2024-02-09 | 2023-12-31 | 0000950170-24-013047 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062177 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000950170-23-040694 | EDGAR | — |
| 2023-02-09 | 2022-12-31 | 0000950170-23-002383 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0000950170-22-023921 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001564590-22-028805 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-16 | 0001104659-26-028015 | EDGAR | 3K words |
| 2026-02-06 | 0001193125-26-040294 | EDGAR | — |
| 2026-01-08 | 0001104659-26-002134 | EDGAR | — |
| 2025-12-15 | 0001104659-25-120861 | EDGAR | — |
| 2025-11-07 | 0001193125-25-270995 | EDGAR | — |
| 2025-10-14 | 0001104659-25-098884 | EDGAR | — |
| 2025-09-17 | 0001104659-25-090861 | EDGAR | — |
| 2025-08-29 | 0001104659-25-085779 | EDGAR | — |
| 2025-08-08 | 0001193125-25-176020 | EDGAR | — |
| 2025-07-29 | 0001104659-25-071781 | EDGAR | — |
346 total filings indexed. 318 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001737927 |
| Ticker | CGC |
| Exchange | Nasdaq |
| SIC | 2833: Medicinal Chemicals & Botanical Products |
| Incorporated | Z4 |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: f5f79e00f3ddef8b597cfbe1108f204461353947ae55f9701c72bc279abc5ecb
parent: f885763cf625136ddf1f19e40e3b5cb73e783fcc8ef905dfde6e40b0252d3568
content hash: bb3b15559d3a5d764c0a85b1102a0a7735d5bf23894a8d29e323295cb4812f1d
signed: 2026-04-13T04:44:17.531Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf